180 related articles for article (PubMed ID: 11697709)
1. The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion.
Heilmann L; von Tempelhoff GF; Kuse S
Clin Appl Thromb Hemost; 2001 Oct; 7(4):281-5. PubMed ID: 11697709
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria.
Abdullahi ZG; Abdul MA; Aminu SM; Musa BO; Amadu L; Jibril el-BM
Ann Afr Med; 2016; 15(3):133-7. PubMed ID: 27549418
[TBL] [Abstract][Full Text] [Related]
3. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
Rai RS; Clifford K; Cohen H; Regan L
Hum Reprod; 1995 Dec; 10(12):3301-4. PubMed ID: 8822463
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between pregnancy loss and antiphospholipid antibody].
Zhang X; Qian M; Liu S
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):10-2. PubMed ID: 10682448
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach.
Rai RS; Regan L; Clifford K; Pickering W; Dave M; Mackie I; McNally T; Cohen H
Hum Reprod; 1995 Aug; 10(8):2001-5. PubMed ID: 8567830
[TBL] [Abstract][Full Text] [Related]
11. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.
Al Jameil N; Tyagi P; Al Shenefy A
Int J Clin Exp Pathol; 2015; 8(3):3204-9. PubMed ID: 26045841
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
Rai R; Cohen H; Dave M; Regan L
BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and fetal death.
Oshiro BT; Silver RM; Scott JR; Yu H; Branch DW
Obstet Gynecol; 1996 Apr; 87(4):489-93. PubMed ID: 8602296
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome.
Venkat-Raman N; Backos M; Teoh TG; Lo WT; Regan L
Obstet Gynecol; 2001 Aug; 98(2):235-42. PubMed ID: 11506839
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
Lee RM; Branch DW; Silver RM
Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae.
van der Spuy ZM; Bird AR; Lindow SW; Bruce C
S Afr Med J; 1993 May; 83(5):319-21. PubMed ID: 8211423
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome and recurrent miscarriages.
Vinatier D; Dufour P; Cosson M; Houpeau JL
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):37-50. PubMed ID: 11311759
[TBL] [Abstract][Full Text] [Related]
18. The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta-analysis.
Xu J; Chen D; Duan X; Li L; Tang Y; Peng B
Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1523-1533. PubMed ID: 31131876
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.
Franklin RD; Kutteh WH
Hum Reprod; 2002 Nov; 17(11):2981-5. PubMed ID: 12407061
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies in pregnancy.
Birdsall M; Pattison N; Chamley L
Aust N Z J Obstet Gynaecol; 1992 Nov; 32(4):328-30. PubMed ID: 1290429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
